Evidence map›Paper›PMID 24994918›Full record

GuidelineJournal of the National Comprehensive Cancer Network : JNCCN2014

Survivorship: cognitive function, version 1.2014.

Crystal S Denlinger, Jennifer A Ligibel, Madhuri Are, K Scott Baker, Wendy Demark-Wahnefried, Debra L Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H Ku and 20 more

Abstract readGuideline
In one paragraph

Guideline in Journal of the National Comprehensive Cancer Network : JNCCN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Rehabilitation in patients with primary brain tumors: a scoping review of current guideline recommendations.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  7. Article
  8. Analysis of the current status and influencing factors of cognitive impairment in patients with different cancer types: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Neurocognitive efficiency in breast cancer survivorship: A performance monitoring ERP study.International journal of psychophysiology : official journal of the International Organization of Psychophysiology · 2021
    Article
  18. Relationship of perceived everyday cognitive function and work engagement in breast cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  19. Cognitive Function in Older Adults With Cancer: Assessment, Management, and Research Opportunities.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Review
  20. Long-Term Cognitive Dysfunction in Cancer Survivors.Frontiers in molecular biosciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Crystal S Denlinger
Jennifer A Ligibel
Madhuri Are
K Scott Baker
Wendy Demark-Wahnefried
Debra L Friedman
Mindy Goldman
Lee Jones
Allison King
Grace H Ku
Elizabeth Kvale
Terry S Langbaum
Kristin Leonardi-Warren
Mary S McCabe
Michelle Melisko
Jose G Montoya
Kathi Mooney
Mary Ann Morgan
Javid J Moslehi
Tracey O'Connor
Linda Overholser
Electra D Paskett
Muhammad Raza
Karen L Syrjala
Susan G Urba
Mark T Wakabayashi
Phyllis Zee
Nicole R McMillian
Deborah A Freedman-Cass
National Comprehensive Cancer Network

Funding

Women's Health Initiative Cancer Survivor CohortUM1CA173642 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ANDERSON, GARNET L., CAAN, BETTE J · 2013 to 2018
$12.1M
Internet Studies to Enhance Long Term Survivorship after Hematologic MalignancyR01CA160684 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SYRJALA, KAREN LESLIE · 2011 to 2015
$3.4M
NCI NIH HHS R01 CA160684NCI NIH HHS UM1 CA173642
6 · The paper itself

Abstract

Cognitive impairment is a common complaint among cancer survivors and may be a consequence of the tumors themselves or direct effects of cancer-related treatment (eg, chemotherapy, endocrine therapy, radiation). For some survivors, symptoms persist over the long term and, when more severe, can impact quality of life and function. This section of the NCCN Guidelines for Survivorship provides assessment, evaluation, and management recommendations for cognitive dysfunction in survivors. Nonpharmacologic interventions (eg, instruction in coping strategies; management of distress, pain, sleep disturbances, and fatigue; occupational therapy) are recommended, with pharmacologic interventions as a last line of therapy in survivors for whom other interventions have been insufficient.

Indexed as

Adaptation, PsychologicalPain ManagementQuality of LifeBenzhydryl CompoundsBrain NeoplasmsCentral Nervous System StimulantsCognition DisordersFatigueHumansMethylphenidateModafinilOccupational TherapySleep Wake DisordersSurvival RateTreatment OutcomeWakefulness-Promoting AgentsBenzhydryl CompoundsCentral Nervous System StimulantsMethylphenidateModafinilWakefulness-Promoting Agents

Identifiers

PMID24994918
PMCPMC4465252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.